scholarly journals Psychological Impacts of COVID-19 on people with Asthma, Allergic Rhinitis and Food Allergy

Author(s):  
Alyssa G. Burrows ◽  
Anne K. Ellis
2017 ◽  
Vol 70 (Suppl. 2) ◽  
pp. 38-45 ◽  
Author(s):  
Michael D. Cabana

Asthma, eczema, food allergy, and allergic rhinitis are some of the most common pediatric, chronic conditions in the world. Breastfeeding is the optimal way to feed all infants. For those infants who are exposed to infant formula, some studies suggest that certain partially hydrolyzed or extensively hydrolyzed formulas may decrease the risk of allergic disease compared to nonhydrolyzed formulas for children with a family history of atopic disease. Overall, there is some evidence to suggest that partially hydrolyzed whey formulas and extensively hydrolyzed casein formulas may decrease the risk of developing eczema for infants at high risk of allergic disease. The evidence for a preventive effect of hydrolyzed formulas on allergic rhinitis, food allergy, and asthma is inconsistent and insufficient. Finally, the qualitative changes to the peptides by the method of hydrolysis, not just the degree of protein hydrolysis, may have a large influence on the preventive effect of a particular infant formula for the potential risk of allergic disease. As a result, it may be difficult to generalize findings from clinical studies using a specific infant formula to other infant formulas from different manufacturers using different methods of hydrolysis. Further clinical studies are needed to help clinicians identify which infants may benefit from early intervention, as well as which specific hydrolyzed formulas are best suited to decrease the risk of future allergic disease.


2021 ◽  
Vol 38 (1) ◽  
pp. 96-101
Author(s):  
Beata Cudowska ◽  
Magdalena Pawłowicz ◽  
Dariusz Lebensztejn

2019 ◽  
Vol 109 (Supplement_1) ◽  
pp. 890S-934S ◽  
Author(s):  
Julie E Obbagy ◽  
Laural K English ◽  
Yat Ping Wong ◽  
Nancy F Butte ◽  
Kathryn G Dewey ◽  
...  

ABSTRACTBackgroundNutrition during infancy and toddlerhood may influence health and disease prevention across the life span. Complementary feeding (CF) starts when human milk or infant formula is complemented by other foods and beverages, beginning during infancy and continuing to age 24 mo.ObjectivesThe aim of this study was to describe systematic reviews conducted for the USDA and the Department of Health and Human Services Pregnancy and Birth to 24 Months Project to answer the following question: What is the relationship between the timing of the introduction of complementary foods and beverages (CFBs), or types and amounts of CFBs consumed, and the development of food allergy, atopic dermatitis/eczema, asthma, and allergic rhinitis?MethodsThe literature was searched using 4 databases (CINAHL, Cochrane, Embase, PubMed) to identify articles published from January 1980 to February 2017 that met predetermined inclusion criteria. For each study, data were extracted and risk of bias was assessed. The evidence was qualitatively synthesized to develop a conclusion statement, and the strength of the evidence was graded.ResultsThirty-one included articles addressed the timing of CFB introduction, and 47 articles addressed the types and amounts of CFBs consumed.ConclusionsModerate evidence suggests that there is no relationship between the age at which CF first begins and the risk of developing food allergy, atopic dermatitis/eczema, or childhood asthma. Limited to strong evidence, depending on the specific food, suggests that introducing allergenic foods in the first year of life (after 4 mo) does not increase the risk of food allergy and atopic dermatitis/eczema but may prevent peanut and egg allergy. There is not enough evidence to determine a relationship between diet diversity or dietary patterns and atopic disease. Research is needed to address gaps and limitations in the evidence on CF and atopic disease, including research that uses valid and reliable diagnostic measures and accounts for key confounders and potential reverse causality.


2002 ◽  
Vol 81 (3) ◽  
pp. 164-167
Author(s):  
Jack L. Pulec

This is a preliminary report of a new method of treating otolaryngic allergy with enzyme-potentiated desensitization (EPD). The nature of EPD and its use in otolaryngology are described. Thirty-six patients have been treated and followed in a private medical practice since February 1997. This article reviews the clinical features of EPD and provides six cases as examples; the clinical features described include allergic rhinitis, serous otitis media, asthma, dermatitis, fixed food allergy, and Ménière's disease. EPD is an effective technique for the treatment of otolaryngic allergy and offers advantages over conventional techniques.


Allergy ◽  
2018 ◽  
Vol 73 (11) ◽  
pp. 2182-2191 ◽  
Author(s):  
Áine Hennessy ◽  
Jonathan O'B Hourihane ◽  
Lucio Malvisi ◽  
Alan D. Irvine ◽  
Louise C. Kenny ◽  
...  

Author(s):  
Mariana C. Castells

Chapter 100 dicusses allergy and immunology, including allergic rhinitis, conjunctivitis, asthma, urticaria and angiodema, ABPA, food allergy, anaphylaxis, mastocytosis, and immunodeficiencies.


Allergy ◽  
2005 ◽  
Vol 60 (9) ◽  
pp. 1165-1171 ◽  
Author(s):  
C. Penard-Morand ◽  
C. Raherison ◽  
C. Kopferschmitt ◽  
D. Caillaud ◽  
F. Lavaud ◽  
...  

2015 ◽  
Vol 135 (2) ◽  
pp. AB10
Author(s):  
Sheva K. Chervinskiy ◽  
Lisa Smeester ◽  
Michael D. Kulis ◽  
David B. Peden ◽  
Brian P. Vickery ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document